Dr. Alper

Dr. Alper

Feb 06, 2018

Group 6 Copy 160
0
    Please wait...

    About This Project

    Pancreatic cancer is the third leading cause of cancer-related death in the US, and expected to become the second leading cause of cancer death by 20201. Pancreatic cancer is frequently not diagnosed until it has metastasized resulting in 5-year survival rate of 8%. We will identify novel tumor markers to detect pancreatic cancer at an early stage.

    1: Pancreatic Cancer Action Network 2016

    Recent Lab Notes From This Project

    Blast off!

    Browse Other Projects on Experiment

    Related Projects

    Targeted Drug Delivery by using Magnetic Nanoparticles

    What if we could use a novel approach for delivering currently injectable drugs to the body without syringes...

    Gene therapy against vision loss in the elderly

    Retinal pigment epithelium (RPE) degeneration is a key feature of age-related macular degeneration (AMD...

    Target-based drug discovery for coronavirus disease 2019

    Therapeutics in any modality to combat Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infections...

    Backer Badge Funded